Order Article Reprints

Donnez J, Donnez O, Tourniaire J, Brethous M, Bestel E, Garner E, Charpentier S, Humberstone A, Loumaye E. Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. Journal of Clinical Medicine. 2021; 10(24):5794. https://doi.org/10.3390/jcm10245794

Donnez, Jacques, Olivier Donnez, Jean Tourniaire, Michel Brethous, Elke Bestel, Elizabeth Garner, Sébastien Charpentier, Andrew Humberstone, and Ernest Loumaye. 2021. "Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration" Journal of Clinical Medicine 10, no. 24: 5794. https://doi.org/10.3390/jcm10245794

Donnez, J., Donnez, O., Tourniaire, J., Brethous, M., Bestel, E., Garner, E., Charpentier, S., Humberstone, A., & Loumaye, E. (2021). Uterine Adenomyosis Treated by Linzagolix, an Oral Gonadotropin-Releasing Hormone Receptor Antagonist: A Pilot Study with a New ’Hit Hard First and then Maintain’ Regimen of Administration. Journal of Clinical Medicine, 10(24), 5794. https://doi.org/10.3390/jcm10245794